Jerome Stevens Unithroid Marketing Will Emphasize NDA Approval
Executive Summary
Unithroid's status as an NDA-approved drug will be the focal point of Jerome Stevens Pharmaceuticals' marketing efforts for the levothyroxine tablets.
You may also be interested in...
Digoxin Timelines: Unapproved Tablets Can Remain 30 Days, Elixirs Two Years
Roxane Laboratories plans to submit an NDA for its digoxin elixir product in November, the company says
Digoxin Timelines: Unapproved Tablets Can Remain 30 Days, Elixirs Two Years
Roxane Laboratories plans to submit an NDA for its digoxin elixir product in November, the company says
King Levoxyl NDA Approval Anticipated In May Ahead of FDA August Deadline
King expects FDA to approve its Levoxyl NDA by the end of May, the company's President and Chief Operating Officer Jeff Gregory said during a conference call Feb. 20.